Medical Research Leaders, Innovators and Investors Come to New York to Forge Partnerships, Speed Cures
WASHINGTON, DC--(Marketwired - Nov 5, 2014) - On Nov. 16-18, nearly 1,000 medical research leaders, investors and decision-makers will come to New York City for the 6th annual Partnering for Cures meeting. Convened by FasterCures, a Washington-based center of the Milken Institute, this unique conference brings together innovators from across all sectors of the medical research enterprise -- academic scientists, federal policymakers, biotechnology and pharmaceutical executives, life science investors, foundations and patients -- to forge the partnerships needed to speed the path of promising discoveries from lab to patient.
"There are so many positive changes underway that are driving us towards a more open, collaborative, patient-driven system," said Margaret Anderson, executive director of FasterCures. "But there is also a vast to-do list to accept this change and advance it. That's what Partnering for Cures is all about -- breaking down the barriers that stand in the way of medical progress and working together to reduce the time and cost of R&D."
Partnering for Cures combines the outcomes-oriented approach of investor conferences with the networking environment of industry partnering meetings. It helps attendees find solutions to some of the thorniest challenges in medical research. Topics include:
- Putting patients in patient-centeredness, not just in word but in deed
- The future of U.S. research leadership
- Redefining the impact of biomedical research investments
- The price of innovation: Who defines 'value'?
- The blurring boundary between university and marketplace
- And many more
- Anna Barker, Professor and Director, Transformative Healthcare Networks; Co-Director, Complex Adaptive Systems Network, Arizona State University
- ShaAvhrée Buckman-Garner, Director, Office of Translational Sciences, Center for Drug Evaluation and Research, U.S. Food and Drug Administration
- Atul Butte, Chief of the Division of Systems Medicine and Associate Professor of Pediatrics, Medicine, and Computer Science, Stanford University
- Francis Collins, Director, National Institutes of Health
- Meryl Comer, President, Geoffrey Beene Foundation Alzheimer's Initiative; Founder, WomenAgainstAlzheimers
- The Honorable Diana DeGette, Chief Deputy Whip, U.S. House of Representatives
- Deborah Dunsire, President & CEO, FORUM Pharmaceuticals
- Esther Dyson, Founder, HICCup
- Ilan Ganot, Founder and CEO, Solid Ventures
- Kathy Giusti, Founder and Executive Chairwoman, Multiple Myeloma Research Foundation and Multiple Myeloma Research Consortium
- Laurie Glimcher, Dean, Weill Cornell Medical College
- Michel Goldman, Director, Innovative Medicines Initiative
- Allan Jones, CEO, Allen Institute for Brain Science
- Michael Kolodziej, National Medical Director, Oncology Solutions, Office of the Chief Medical Officer, Aetna
- Craig Lipset, Head, Clinical Innovation, Worldwide Research & Development, Pfizer Inc.
- Eric Minikel and Sonia Vallabh, Co-Directors, Prion Alliance
- Richard Pops, Chairman and CEO, Alkermes
- Katherine Priestley, Managing Partner, Park Vale Capital
- Melinda Richter, Head, Janssen Labs, Johnson & Johnson
- Benjamin Seet, Executive Director, Biomedical Research Council, A*STAR
- The Honorable Fred Upton, Chairman, Committee on Energy and Commerce, U.S. House of Representatives
- Pascale Witz, Executive Vice President, Global Divisions & Strategic Development, Sanofi
- And many more.
In a new addition to the Partnering for Cures agenda, top entrepreneurs will describe how their mobile/digital health technology applications will increase patient participation in biomedical R&D. Moderated by a panel of experts representing entrepreneurship, drug development, clinical care, and disease philanthropy, Entrepreneurs for Cures will position three innovators with transformative products before a cross-sector audience ready to change the R&D paradigm.
Held at the Grand Hyatt New York, Partnering for Cures is open to the public and to registered media. For registration information, go to www.partneringforcures.org/registration. Members of the press may apply here to receive complimentary registration.
Complete information about Partnering for Cures, including a full program and a list of speakers confirmed to date, is available at www.partneringforcures.org.
FasterCures, a center of the Milken Institute, is an action tank, determined to remove barriers to medical progress. We have only one goal: to save lives by speeding up and improving the medical research system.